Evolution of microbial resistance to fluorquinolones in tertiary hospitals;Evolucion de la resistencia microbiana a fluorquinolonas en un hospital terciario

Actas Urologicas Espanolas

Volumn 24, Issue 5, 2000, Pages 381-387

  Queipo Zaragoza, J A ^a   Budia Alba, A ^a   Garcia, E Mascaros ^a   Gomez Ferrer Lozano, A ^a   Gobernado Serrano, M ^a   Jimenez Cruz, J F ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Epidemiology; Quinolones; Resistance; Urinary infection

Indexed keywords

ANTIINFECTIVE AGENT; QUINOLONE DERIVATIVE; 7 (3 AMINO 1 PYRROLIDINYL) 1 CYCLOPROPYL 6 FLUORO 1,4 DIHYDRO 4 OXO 1,8 NAPHTHYRIDINE 3 CARBOXYLIC ACID; AMIFLOXACIN; CINOXACIN; CIPROFLOXACIN; CLINAFLOXACIN; DIFLOXACIN; ENOXACIN; FLEROXACIN; GATIFLOXACIN; GEMIFLOXACIN; GREPAFLOXACIN; LEVOFLOXACIN; LOMEFLOXACIN; NADIFLOXACIN; NALIDIXIC ACID; NORFLOXACIN; OFLOXACIN; PEFLOXACIN; PIPEMIDIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; ROSOXACIN; SPARFLOXACIN; TOSUFLOXACIN; TROVAFLOXACIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; CHILD; HOSPITAL; HUMAN; MICROBIOLOGY; MIDDLE AGED; PRESCHOOL CHILD; RETROSPECTIVE STUDY; URINARY TRACT INFECTION; ENTEROBACTER; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; HOSPITAL INFECTION; KLEBSIELLA; NONHUMAN; PROTEUS MIRABILIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, MICROBIAL; FLUOROQUINOLONES; HOSPITALS; HUMANS; MIDDLE AGED; RETROSPECTIVE STUDIES; URINARY TRACT INFECTIONS;

EID: 0033624532     PISSN: 02104806     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0210-4806(00)72467-3     Document Type: Article

References (27)

1. R. Davis A. Markham J.A. Balfour Ciprofloxacin. An update review of its pharmacology, therapeutic efficacy and tolerability Drugs 51 1996 1.019 1.074
2. J.T. Smith Chemistry and mode of action of 4-quinolone agents Fortschr Antimikrob Chemother 3 1984 493 508
3. N.R. Cozzarelli DNA gyrase and the supercoilling of DNA Science 207 1980 953 960
4. L.L. Shen A. Pernett Mechanism of inhibition of DNA gyrase by analogs of nalidixic acid: The target of the drug is DNA Proc Natl Acad Sci USA 82 1985 307 311
5. J.W. Litle D.W. Mount The SOS regulatory system of E. coli Cell 29 1982 11 22
6. K. Rohatgi J.B. Courtright Major change in the structure and morphology of the bacterial nucleotide after treatment of cells with quinolones Siporin cols The New Generation of Quinolones 1990 Marcel Dekker New York 317 326
7. L. Ferrero B. Cameron B. Manse Cloning and primary structure of Staphylococcus aureus DNA topoisomerase IV: A primary target of fluorquinolones Mol Microbiol 13 1994 641 653
8. K.G. Miller F.L. Liu A.T. Englund A homogeneous type II DNA topoisomerase from Hela cell nuclei J Biol Chem 256 1981 9.334 9.335
9. V. Korten W.M. Huang B.E. Murray Analysis by PCR and direct DNA sequencing of gyrA mutations associated with fluorquinolone resistance in Enterococcus faecalis Antimicrob Agents Chemother 38 1994 2.091 2.094
10. O. Heisig H. Schedletzky P.H. Falkenstein Mutations in the gyrA gene of a highly fluorquinolone- resistant clinical isolate of Escherichia coli Antimicrob Agents Chemother 37 1993 696 701
11. M.E. Cullen A.W. Wyke R. Kuroda L.M. Fisher Cloning and characterization of DNA-gyrase a gen from E. coli that confers clinical resistance to 4-quinolones Antimicrob Agents Chemother 33 1989 886 894
12. A. Denis N.J. Moreau Mechanisms of quinolone resistance in clinical isolates: Acumulation of various hydrophobicity and analisis of membrane composition J Antimicrob Chemother 32 1993 379 392
13. B. Wiedemann P. Heisig Mechanisms of quinolone resistance Infection 22 Suuppl. 2 1994 73 79
14. D.C. Hooper N.G. Eva The threat of quinolone resistance Can J Antimicrob Chemother 32 1993 195 213
15. D.C. Hooper J.S. Wolfson M.N. Swartz Mechanism of action and resistance to ciprofloxacin Am J Med 82 Sup. 4ª 1987 12 20
16. M. Michea-hamzehpour Y.X. Furet J.C. Pechere Role of protein D2 and lipopolysaccharide in difusion of quinolones through the outer membrane of Pseudomonas aeruginosa Amtimicrob Agents Chemother 35 1991 2.091 2.097
17. G. Padberg L.E. Nilsson S. Svensson Development of quinolone-imipenem cross resistance in Pseudomonas aeruginosa during exposure to ciprofloxacin Antimicrob Agents Chemother 34 1990 2.142 2.147
18. E. Pérez-trallero M. Urbieta D. Giménez Ten-year survey of quinolone resistance in E. coli causing urinary tract infections Eur J Clin Microbiol Infect Dis 12 1993 349 351
19. gómez C López B. De escalante B. Moles M.L. Aísa Estudio de la resistencia a quinolonas por el género Campylobacter y las enterobacterias durante los años 1990 y 1991 Rev Esp Quimioter 6 1993 155 159
20. R. Alonso A. Fernández-aránguiz K. Colom L. Gallego A. Morla A. Umaran R. Cisterna Estudio mluticéntrico de la actividad “in vitro” de ofloxacino Rev Esp Quimioter 6 1993 160 163
21. L. Martínez A.I. Suárez R. Carranza E.J. Perea Resistencia a ciprofloxacino en bacilos gramnegativos. Aspectos epidemiológicos Enferm Infecc Microbiol Clin 11 1993 474 478
22. M.F. Breznes Y. Rodríguez A. Canut Disminucion de la sensibilidad a quinolonas en uropatógenos durante el periodo 1989-1993 Rev Esp Quimioter 7 1994 341
23. R. Martínez B. Orden A. Franco Evolución de las resistencias a ciprofloxacino en bacteriurias extrahospitalarias Rev Esp Quimioter 7 1994 351
24. J.C. Rodríguez M. Ruíz M. Elía G. Royo Sensibilidadde los patógenos aislados de infecciones urinarias Rev Esp Quimioter 8 1995 73 74
25. F.J. Pardo R. Moreno J.V. Galiano R.E. García coli resistente a ciprofloxacino en un hospital general: aspectos epidemiológicos Rev Esp Quimioter 8 1995 289 293
26. A. García F.J. Pardo R. Moreno J.V. Galiano Bacilos gram-negativos aislados en un hospital general: alta tasa de resistencias frente a ciprofloxacino Enferm Infecc Microbiol Clin 14 1996 276 277
27. J.I. Cardenal E. García M. Macías R. Iñíguez Resistencia de E. coli a las quinolonas en un área de Cáceres (Extremadura Rev Esp Quimioter 9 1996 266 269